中华创伤杂志
中華創傷雜誌
중화창상잡지
Chinese Journal of Traumatology
2013年
5期
446-450
,共5页
张树葆%印素娜%张学广%耿凤阳%李忠民%种宗雷
張樹葆%印素娜%張學廣%耿鳳暘%李忠民%種宗雷
장수보%인소나%장학엄%경봉양%리충민%충종뢰
脑损伤%弥漫性轴索损伤%引流术%淀粉样β蛋白
腦損傷%瀰漫性軸索損傷%引流術%澱粉樣β蛋白
뇌손상%미만성축색손상%인류술%정분양β단백
Brain injuries%Diffuse axonal injury%Drainage%Amyloid beta-protein
目的 观察持续腰大池引流对弥散性轴索损伤(diffuse axonal injury,DAI)患者脑脊液以及血浆中淀粉样β蛋白亚型(Aβ1-42)水平的影响及其临床意义.方法 选择81例DAI患者并随机分为治疗组(42例)和对照组(39例).对照组采用常规治疗,治疗组在常规治疗基础上加用持续腰大池引流治疗14 d.采用ELISA法检测治疗前及治疗后l,5,9,14 d患者脑脊液和血浆中Aβ1-42水平,6个月后采用格拉斯哥预后评分(Glascow outcome scale,GOS)评定预后.结果 两组患者脑脊液和血浆中Aβ142水平均先升高再逐渐降低,而治疗组Aβ1-42水平降低较早,幅度较大.治疗14 d后,两组Aβ1-42水平差异有统计学意义(P<0.05).6个月后随访,治疗组GOS为(4.1±0.5)分,对照组为(3.4±0.3)分(P<0.05).结论 持续腰大池引流可改善DAI患者的预后,可能与其降低患者脑脊液及血浆中Aβ1-42水平有一定关系.
目的 觀察持續腰大池引流對瀰散性軸索損傷(diffuse axonal injury,DAI)患者腦脊液以及血漿中澱粉樣β蛋白亞型(Aβ1-42)水平的影響及其臨床意義.方法 選擇81例DAI患者併隨機分為治療組(42例)和對照組(39例).對照組採用常規治療,治療組在常規治療基礎上加用持續腰大池引流治療14 d.採用ELISA法檢測治療前及治療後l,5,9,14 d患者腦脊液和血漿中Aβ1-42水平,6箇月後採用格拉斯哥預後評分(Glascow outcome scale,GOS)評定預後.結果 兩組患者腦脊液和血漿中Aβ142水平均先升高再逐漸降低,而治療組Aβ1-42水平降低較早,幅度較大.治療14 d後,兩組Aβ1-42水平差異有統計學意義(P<0.05).6箇月後隨訪,治療組GOS為(4.1±0.5)分,對照組為(3.4±0.3)分(P<0.05).結論 持續腰大池引流可改善DAI患者的預後,可能與其降低患者腦脊液及血漿中Aβ1-42水平有一定關繫.
목적 관찰지속요대지인류대미산성축색손상(diffuse axonal injury,DAI)환자뇌척액이급혈장중정분양β단백아형(Aβ1-42)수평적영향급기림상의의.방법 선택81례DAI환자병수궤분위치료조(42례)화대조조(39례).대조조채용상규치료,치료조재상규치료기출상가용지속요대지인류치료14 d.채용ELISA법검측치료전급치료후l,5,9,14 d환자뇌척액화혈장중Aβ1-42수평,6개월후채용격랍사가예후평분(Glascow outcome scale,GOS)평정예후.결과 량조환자뇌척액화혈장중Aβ142수평균선승고재축점강저,이치료조Aβ1-42수평강저교조,폭도교대.치료14 d후,량조Aβ1-42수평차이유통계학의의(P<0.05).6개월후수방,치료조GOS위(4.1±0.5)분,대조조위(3.4±0.3)분(P<0.05).결론 지속요대지인류가개선DAI환자적예후,가능여기강저환자뇌척액급혈장중Aβ1-42수평유일정관계.
Objective To observe influence of continuous lumbar cistern drainage on levels of amyloid β-peptide (Aβ) subtype (Aβ1-42) in cerebrospinal fluid and plasma in patients with diffuse axonal injury (DAI) and investigate its clinical significance.Methods Eighty-one DAI patients were enrolled and randomized into treatment group (42 cases) and control group (39 cases).Patients in control group received simple conventional therapy,while the patients in treatment group received not only conventional therapy but 14 days of continuous lumbar cistern drainage.Levels of Aβ1-42 in cerebrospinal fluid and plasma were detected by ELISA assay before therapy and at 1,5,9,and 14 days after therapy.Prognosis was assessed using GOS at 6 months after therapy.Results Levels of Aβ1-42 in cerebrospinal fluid and plasma showed a decrease in the first place and a gradual decrease afterwards in both groups,but a bigger and earlier drop of Aβ1-42 levels was observed in treatment group.Two groups showed significant difference of Aβ1-42 levels at day 14 (P < 0.05).At 6 months after therapy,GOS score between treatment and control groups was (4.1 ± O.5) and (3.4 ± 0.3) points respectively (P <0.05).Conclusion Continuous lumbar cistern drainage improves the prognosis of DAI and this may relates to the decrease of Aβ1-42 levels in cerebrospinal fluid and plasma.